Dr. Brian Kelley, a cardiologist with Novant Health, was in the studio to discuss new treatment advancements that offer additional options for some patients. Blue Cross and Blue Shield of North ...

WILMINGTON, N.C. (AP) - An experimental pill is providing new hope for patients with advanced pancreatic cancer, one of the deadliest malignancies that often shows no early symptoms, according to the ...

Section 1. Purpose. The United States continues to lead the world in Artificial Intelligence (AI) because of the enormous talent and innovation of our AI industry, and because we refuse to stifle this ...

As part of a clinical study, the Early Clinical Trial Unit (ECTU) at NCT/UCC Dresden tested the cancer immunotherapy IMA401 for the first time in patients with advanced solid tumors. IMA401 is a ...

A cancer treatment delivered through a simple injection eliminated tumours in some patients and significantly shrank them in others during an international clinical trial involving people with ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not ...

A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options. This novel approach, ...

A targeted treatment that triggers the death of cancer cells has shown promise for patients with advanced bowel cancer when used alongside chemotherapy, an early trial has found. The combination ...